Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?
about
Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds En[Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1,492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE)].Phenotypic and clinical differences between Caucasian and South Asian patients with psoriatic arthritis living in North East London.Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.Psoriatic arthritis assessment tools in clinical trials.Seronegative spondyloarthropathies: to lump or split?Measuring disease activity in psoriatic arthritis.Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapyAxial psoriatic arthritis: an intriguing clinical entity or a subset of an intriguing disease?Psoriatic arthritis: phenotypic variance and nosology.Patient involvement in outcome measures for psoriatic arthritis.Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR)Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy.Patient-Reported Outcomes in Psoriatic Arthritis.Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis.Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.Metabolic syndrome in psoriatic arthritis patients: a cross-sectional study.
P2860
Q26862017-791F59F8-72E4-4616-887A-F28754B713B8Q30881987-301F67BD-242C-4231-959B-D2D3FB5AF235Q34318229-76866062-41EC-4F9C-8A77-ADABC847BFC4Q34570563-2FD19C4B-40E8-42B5-A223-256EF4B4C80AQ35579462-353871D3-A1A6-45D6-AC02-2AB954E3C5D4Q36040093-8A909CB2-BB42-4B75-A40B-9709157E1054Q36520126-188B7CD3-41A5-4442-B5D9-4E85B5C66B9DQ36907291-FEAACCBA-05A6-4A89-9542-EF5AE09B14B1Q37031122-3915B2FB-C0D1-4B0B-8FA2-6AEA6353BA0FQ38007111-C02097DC-6E40-4A45-9DAD-35E95A26996BQ38078291-157D845F-E693-4A53-A1CA-D8E4E9E90006Q38195568-EF2FD704-103A-42D0-89EA-F2E10D893006Q38621658-B8183D43-4632-4EF1-A71E-43FD5588EC15Q38710469-0EB1125F-0722-4690-9732-61D84D9595C2Q38822369-7E8AC191-FCF7-4980-B511-079097C5AB43Q45867337-AB441664-8750-4F46-AD86-4FC2EE0FD3E7Q48060906-30978415-C959-499B-B1F5-2DC14D310257Q48661188-AF448597-6434-4E84-88FD-9DB574C2EFE6Q51329205-9C2FE16B-70DB-44C3-A6DF-B202E75A0F48
P2860
Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Could the Bath Ankylosing Spon ...... ents with psoriatic arthritis?
@ast
Could the Bath Ankylosing Spon ...... ents with psoriatic arthritis?
@en
type
label
Could the Bath Ankylosing Spon ...... ents with psoriatic arthritis?
@ast
Could the Bath Ankylosing Spon ...... ents with psoriatic arthritis?
@en
prefLabel
Could the Bath Ankylosing Spon ...... ents with psoriatic arthritis?
@ast
Could the Bath Ankylosing Spon ...... ents with psoriatic arthritis?
@en
P356
P1476
Could the Bath Ankylosing Spon ...... ents with psoriatic arthritis?
@en
P2093
William J Taylor
P304
P356
10.1002/ART.20421
P577
2004-06-01T00:00:00Z